7Baggers
Quarterly
Annual
    Unit: USD2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 2019-07-31 2019-04-30 2019-01-31 2018-10-31 2018-07-31 2018-04-30 2018-01-31 2017-10-31 2017-07-31 2017-04-30 
      
    		                                  
      operating activities:
    		                                  
      net income
    		26,751,000 770,000 -7,275,000 -12,799,000 -4,057,000 -3,817,000 1,687,000 -468,000 -3,437,000 -412,000 -7,798,000 -12,310,000 -19,991,000 -25,839,000 -23,110,000 -24,926,000 -27,592,000 -17,631,000 -18,311,000 -22,041,000 -25,116,000 -29,224,000 -30,577,000 -42,717,000 -29,291,000 -18,959,000 -10,839,000 -24,766,000 -21,096,000 -18,136,000 -16,998,000 -17,062,000 -16,399,000 -16,106,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                  
      depreciation and amortization expense
    		6,788,000 6,855,000 6,430,000 6,287,000 2,851,000 2,963,000 3,180,000 3,536,000 4,421,000 4,668,000 4,485,000 4,396,000 4,315,000 4,387,000 4,293,000 4,557,000 4,216,000 3,717,000 3,073,000 2,352,000               
      bad debt expense
    		667,000 286,000 648,000 654,000 335,000 28,000 299,000 -13,000 -373,000 975,000 -199,000 -110,000 1,141,000 -650,000 427,000 -83,000 728,000 181,000 171,000 60,000 1,557,000 759,000             
      stock-based compensation expense
    		12,962,000 12,659,000 14,689,000 12,693,000 12,333,000 12,065,000 10,626,000 11,758,000 11,565,000 11,012,000 14,088,000 14,822,000 16,082,000 18,086,000 19,025,000 19,455,000 20,402,000 14,598,000 18,405,000 19,287,000 17,230,000 17,372,000 16,853,000 21,092,000 16,609,000 13,216,000 12,290,000 12,922,000 11,028,000 7,993,000 7,358,000    
      amortization of operating lease right-of-use assets
    		2,368,000 2,315,000 2,258,000 2,206,000 2,155,000 2,110,000 2,065,000 2,128,000 2,318,000 2,293,000 2,115,000 2,137,000 2,177,000 2,370,000 2,362,000 2,315,000 2,341,000 2,278,000 2,836,000 2,540,000 3,370,000 3,457,000 3,085,000 3,329,000 3,132,000 1,578,000         
      adjustments to contingent consideration
    		-23,400,000 1,800,000 4,893,000                                
      other
    		232,000 432,000 -1,846,000 -1,232,000 115,000 366,000 189,000 167,000 84,000 100,000 15,000 205,000 673,000 302,000 76,000 135,000 210,000 161,000 -1,078,000 245,000 154,000 190,000             
      changes in operating assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:
    		                                  
      accounts receivable
    		4,142,000 43,140,000 -56,407,000 -6,736,000 7,705,000 54,316,000 -56,733,000 2,308,000 4,329,000 50,614,000 -40,352,000 -15,512,000 3,128,000 42,680,000 -40,423,000 -3,301,000 -4,296,000 41,914,000 -48,292,000 4,301,000 -6,394,000 32,395,000 -42,889,000 -2,019,000 -4,268,000 22,195,000 -20,953,000 -6,713,000 -4,204,000 20,269,000 -20,665,000 -9,539,000 4,631,000 8,537,000 
      prepaid expenses and other current assets
    		2,968,000 -4,985,000 -323,000 3,157,000 -2,571,000 -660,000 3,493,000 -2,200,000 1,119,000 -1,657,000 -556,000 2,969,000 969,000 -5,685,000 3,273,000 -716,000 460,000 1,221,000 -440,000 2,906,000 -2,865,000 -5,064,000 -620,000 816,000 12,000 60,000 -3,420,000 365,000 -3,311,000 -379,000 -2,054,000 582,000   
      costs to obtain revenue contracts
    		3,770,000 3,234,000 -428,000 2,857,000 3,349,000 4,270,000 -236,000 2,500,000 3,225,000 3,329,000 -139,000 590,000 3,200,000 4,383,000 -459,000 -212,000 -2,908,000 -5,534,000 -2,314,000 1,017,000 261,000 3,465,000 -12,148,000 -3,633,000 -2,198,000 -365,000         
      other long term assets
    		984,000 5,863,000 95,000 41,000 135,000 80,000 354,000 -184,000 -368,000 1,094,000 -92,000 276,000 278,000 678,000 -274,000 28,000 171,000 -156,000 -280,000 -159,000 -712,000 -479,000 -948,000 -623,000 855,000 -1,913,000 511,000 -415,000 -15,000 -79,000 -197,000 -42,000 101,000 -220,000 
      accounts payable, accrued expenses and other current liabilities
    		-769,000 834,000 9,856,000 11,830,000 -621,000 -4,028,000 -1,001,000 4,983,000 889,000 -15,047,000 -1,196,000 3,668,000 -4,745,000 4,987,000 -4,335,000 4,552,000 -2,656,000 1,945,000 5,216,000 -182,000 -2,360,000 -4,650,000 5,106,000 3,722,000 5,777,000 -6,338,000 13,647,000 -1,194,000 9,440,000 -4,565,000 2,975,000 881,000   
      unearned revenue
    		-24,764,000 -21,688,000 68,653,000 -32,747,000 -29,673,000 -26,697,000 67,182,000 -23,110,000 -27,987,000 -27,337,000 68,324,000 -10,632,000 -29,635,000 -24,519,000 72,685,000 -13,086,000 -21,151,000 -5,186,000 62,294,000 -18,215,000 -7,216,000 -24,161,000 69,876,000 -15,326,000 -2,497,000 -9,708,000         
      operating lease liabilities
    		-3,513,000 -3,509,000 -2,783,000 -2,570,000 -2,895,000 -2,847,000 -2,795,000 -3,044,000 -2,944,000 -2,904,000 -2,828,000 -2,167,000 -2,840,000 -3,151,000 -2,603,000 1,593,000 -2,848,000 -2,786,000 6,411,000 -1,218,000 1,065,000 2,679,000 532,000 823,000 -1,157,000 -1,242,000         
      other long term liabilities
    		-779,000 -10,281,000 -114,000 -43,000 190,000 160,000 -290,000 66,000 125,000 16,000 78,000 881,000 82,000 -168,000 -1,813,000 -35,000 309,000 341,000 -2,765,000 1,680,000 2,246,000 559,000 87,000 364,000 -232,000 346,000 740,000 0 -3,000 5,000 10,000 69,000 18,000 2,000 
      net cash from operating activities
    		8,407,000 37,725,000 38,346,000 -15,795,000 -10,649,000 38,309,000 28,020,000 -1,573,000 -7,034,000 26,744,000 35,945,000 -10,787,000 -25,166,000 17,861,000 29,124,000 -9,724,000 -32,614,000 35,063,000 24,926,000 -7,427,000 -15,638,000 -657,000 11,666,000 -31,817,000 -11,436,000 819,000 30,820,000 -22,564,000 -4,425,000 1,409,000 -2,079,000 -16,381,000 -5,103,000 -8,346,000 
      investing activities:
    		                                  
      capital expenditures
    		-573,000 -562,000 -316,000 -577,000 -545,000 -647,000 -408,000 -753,000 -623,000 -944,000 -793,000 -1,525,000 -2,231,000 -1,644,000 -1,085,000 -1,778,000 -3,098,000 -7,457,000 -11,165,000 -13,891,000 -18,780,000 -21,275,000 -4,542,000 -2,898,000 -3,618,000 -831,000 -949,000 -1,618,000 -1,131,000 -1,572,000 -927,000 -861,000 -808,000 -1,078,000 
      free cash flows
    		7,834,000 37,163,000 38,030,000 -16,372,000 -11,194,000 37,662,000 27,612,000 -2,326,000 -7,657,000 25,800,000 35,152,000 -12,312,000 -27,397,000 16,217,000 28,039,000 -11,502,000 -35,712,000 27,606,000 13,761,000 -21,318,000 -34,418,000 -21,932,000 7,124,000 -34,715,000 -15,054,000 -12,000 29,871,000 -24,182,000 -5,556,000 -163,000 -3,006,000 -17,242,000 -5,911,000 -9,424,000 
      cash paid in acquisitions, net of cash acquired
    		0 -18,801,000                                 
      net cash from investing activities
    		-573,000 -19,363,000 -316,000 -89,984,000 -545,000 -647,000 -408,000 -753,000 -623,000 -944,000 -793,000 -1,525,000 -2,231,000 -1,644,000 -1,085,000 -1,778,000 -3,098,000 -7,457,000 -11,165,000 -13,891,000 -18,780,000 -21,275,000 -4,542,000 2,502,000 17,482,000 23,866,000 26,951,000 -2,489,000 -7,979,000 11,651,000 7,238,000 971,000 -95,254,000 -1,078,000 
      financing activities:
    		                                  
      proceeds from exercise of stock options
    		321,000 118,000 153,000 346,000 508,000 283,000 635,000 160,000 1,339,000 7,271,000 153,000 36,000 214,000 311,000 3,359,000 1,430,000 2,271,000 12,168,000 3,319,000 6,494,000 4,772,000 1,879,000 2,380,000 3,346,000 4,167,000 5,000,000 3,836,000 4,879,000 5,217,000 4,948,000 6,924,000 2,305,000 241,000 2,140,000 
      proceeds from debt issuance
    		                                  
      repurchase of common stock
    		-17,745,000 -27,635,000 -11,147,000 -6,559,000   0 -12,090,000 -6,413,000 -4,583,000 -8,555,000 -9,973,000 -31,580,000 -27,142,000                     
      payments for taxes related to net share settlement of stock-based compensation awards
    		-11,865,000 -2,137,000 -1,795,000 -5,250,000 -1,742,000 -2,039,000 -2,297,000 -2,968,000 -4,513,000 -3,237,000 -3,283,000                        
      payments of deferred financing costs
    		-818,000 -59,000 -76,000 -118,000 -321,000 -338,000 -58,000 -93,000 -237,000 -64,000 -225,000 -1,000 -215,000 -68,000 0 0 -219,000 -44,000 0 -215,000 -260,000 -394,000 0 0 -97,000 -163,000 0 0   0 0   
      proceeds, net from employee stock purchase plan withholdings
    		878,000 690,000 1,079,000 376,000 922,000 920,000 1,348,000 370,000 1,251,000 925,000 1,206,000 35,000 1,306,000 606,000 1,593,000 650,000 1,926,000 1,483,000 2,142,000 1,144,000 2,184,000 1,483,000 2,192,000 1,431,000 1,779,000 1,868,000 1,716,000 1,468,000 1,258,000 1,221,000     
      net cash from financing activities
    		69,771,000 -29,023,000 -15,328,000 -11,205,000 -834,000 -1,174,000 -372,000 -14,621,000 -8,573,000 312,000 -10,704,000 -11,749,000 -30,275,000 -26,293,000 4,952,000 2,080,000 3,978,000 13,607,000 5,461,000 7,423,000 6,696,000 2,968,000 4,572,000 4,777,000 5,527,000 153,497,000 5,552,000 6,347,000 6,316,000 6,169,000 7,950,000 3,692,000 -736,000 118,698,000 
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		-82,000 4,022,000 -2,053,000                2,193,000 -456,000 2,273,000 -416,000 -374,000 491,000 -435,000 -174,000 95,000 -112,000 -160,000 -193,000     
      net increase in cash, cash equivalents and restricted cash
    		77,523,000 -6,639,000                 21,415,000 -14,351,000 -25,449,000 -19,380,000 11,322,000 -24,047,000 11,138,000 178,008,000   -6,248,000 19,036,000     
      cash, cash equivalents and restricted cash at beginning of period
    		0 138,654,000 0                0 0 0 268,176,000 0 0 0 91,755,000 0 0 0 34,367,000     
      cash, cash equivalents and restricted cash at end of period
    		77,523,000 132,015,000 20,649,000                21,415,000 -14,351,000 -25,449,000 248,796,000 11,322,000 -24,047,000 11,138,000 269,763,000 63,418,000 -18,818,000 -6,248,000 53,403,000     
      changes in operating assets and liabilities, net of assets acquired and liabilities assumed in a business acquisition:
    		                                  
      cash paid in acquisition, net of cash acquired
    		  0                                
      deferred acquisition payments
    		                                  
      supplemental disclosure of cash flow data:
    		                                  
      cash paid on interest
    		                              3,000 0 0 71,000 
      cash paid on income taxes
    		                              11,000 952,000 29,000 2,000 
      net decrease in cash, cash equivalents and restricted cash
    		                                  
      changes in operating assets and liabilities:
    		                                  
      effect of exchange rate changes on cash and cash equivalents
    		    737,000 -558,000 788,000 -1,424,000 -93,000 524,000 3,498,000 -1,577,000 -2,191,000 -3,365,000  -1,542,000 125,000 475,000             146,000 -49,000 237,000 41,000 
      net increase in cash and cash equivalents
    		    -11,291,000 35,930,000   -16,323,000 26,636,000   -59,863,000 -13,441,000   -31,609,000 41,688,000               -100,856,000 109,315,000 
      cash and cash equivalents at beginning of period
    		    0 210,184,000 0 0 0 190,214,000 0 0 0 261,210,000  0 0 230,411,000             0 0 0 24,420,000 
      cash and cash equivalents at end of period
    		    -11,291,000 246,114,000 28,028,000 -18,371,000 -16,323,000 216,850,000 27,946,000 -25,638,000 -59,863,000 247,769,000  -10,964,000 -31,609,000 272,099,000             13,255,000 -11,767,000 -100,856,000 133,735,000 
      net decrease in cash and cash equivalents
    		                                  
      maturities of marketable securities
    		                      0 5,400,000 21,100,000 24,697,000 27,900,000 27,353,000 17,844,000 13,223,000 12,654,000    
      proceeds from common stock offering, net of underwriting discounts and commissions
    		                      0 0 0 147,000,000         
      payments of common stock deferred offering costs
    		                                  
      purchases of marketable securities
    		                          0 -28,224,000   -4,489,000 -11,709,000   
      depreciation and amortization
    		                     2,045,000 2,233,000 2,014,000 1,881,000 1,941,000 1,785,000 1,787,000 1,665,000 1,576,000 1,372,000 1,322,000 1,253,000 1,176,000 
      payments of deferred offering costs
    		                         -208,000     0 0 -2,294,000 -1,969,000 
      benefit from bad debts
    		                      949,000 278,000 -21,000 40,000 190,000 -51,000 277,000 76,000 157,000 152,000 90,000 79,000 
      change in fair value of convertible preferred stock warrant liability
    		                              0 0 0 491,000 
      sales of marketable securities
    		                              0    
      proceeds from initial public offering, net of underwriting discounts and commissions
    		                              0 0 0 123,527,000 
      proceeds from exercise of warrants
    		                              0 0   
      repayments on revolving line
    		                              0 0 0 -5,000,000 
      supplemental disclosures of non-cash investing and financing activities:
    		                                  
      non-cash capital expenditures in accounts payable, accrued expenses and other current liabilities
    		                                  
      stock-based compensation for capitalized software in property and equipment
    		                                  
      conversion of convertible preferred stock to common stock
    		                              0 0 0 120,615,000 
      conversion of convertible preferred stock warrants to common stock warrants
    		                              0 0 0 1,435,000 
      deferred income taxes
    		                       0 -61,000 3,000 11,000 3,000 -35,000 -22,000 -116,000 -19,000 19,000 -13,000 
      amortization of deferred financing costs
    		                       70,000 70,000 47,000 32,000 32,000 32,000 34,000 35,000 36,000 35,000 34,000 
      amortization of (discount) premium on marketable securities
    		                       -7,000 -47,000 -82,000         
      payments of deferred common stock offering issuance costs
    		                       0           
      gain on sale of marketable securities
    		                              0    
      deferred rent
    		                          -381,000 -312,000 -293,000 -305,000 -226,000 -278,000 -310,000 7,000 
      purchases of intangible assets
    		                                  
      proceeds from borrowings on revolving line
    		                                  
      supplemental disclosures of non-cash investing and financing information:
    		                                  
      non-cash capital expenditures, including capitalized stock-based compensation, and items in accounts payable, accrued expenses and other current liabilities
    		                              166,000 155,000   
      deferred offering costs in accounts payable, accrued expenses and other current liabilities
    		                                 2,294,000 
      amortization of premium on marketable securities
    		                           -108,000 8,000 39,000 48,000    
      deferred commissions
    		                           -250,000 -1,947,000 366,000 -3,268,000 -665,000 -122,000 -365,000 
      deferred revenue
    		                           -3,864,000 4,029,000 -5,463,000 29,490,000 2,138,000 -118,000 243,000 
      cash flows from operating activities:
    		                                  
      restricted cash
    		                              0 0 502,000 -2,000 
      cash flows from investing activities:
    		                                  
      acquisitions, net of cash acquired
    		                                  
      cash flows from financing activities:
    		                                  
      proceeds from sale of common stock
    		                                  
      share repurchase and stock option settlement
    		                                  
      proceeds from employee stock purchase plan withholdings
    		                              1,026,000    
      common stock issued for the acquisition of inner balloons
    		                                  
      stock-based compensation
    		                                5,003,000 4,062,000 
      proceeds from employee stock purchase plan
    		                                  
      prepaid expenses and other assets
    		                                 -1,277,000 
      accounts payable, accrued expenses and other liabilities
    		                                 -4,994,000 
      purchase of capital expenditures in accounts payable, accrued expenses and other current liabilities
    		                                 231,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.